Naseem Eisa

Naseem Eisa practices at Community Health Partners in Clovis, California.

Naseem Eisa's NPI, 1659600112, was assigned on December 12, 2009. Naseem Eisa graduated from Damascus University Faculty of Medicine in 2008. Naseem Eisa holds California license A137168.

Naseem Eisa's primary practice is Community Health Partners, at 789 N Medical Center E Dr, Clovis, CA 93611 in Fresno County. The practice phone is (559) 324-4952.

Naseem Eisa's primary practice is Community Health Partners in Clovis, California. Naseem Eisa is also affiliated with Clovis Community Medical Center. The medical group on file is Community Health Partners. Dmand AI also links Naseem Eisa to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Naseem Eisa practices, 4 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Naseem Eisa's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Naseem Eisa is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dmand AI has Naseem Eisa's licenses on file in 4 states: California, Ohio, Massachusetts and Illinois.

Dmand AI lists acute kidney failure, chronic diabetes, chronic hypertension, diabetic emergency, enlarged thyroid, fluid and electrolyte imbalances, high cholesterol and hypercalcemia among the conditions Naseem Eisa treats.

CMS data shows 84,653 Medicare services from Naseem Eisa across 17 procedure codes in 2024, for 850 Medicare patients. Medicare paid $1,133,664 for them. Every service was in an office.

CMS counts 850 Medicare patients who saw Naseem Eisa in 2024. The largest group is 65 to 74, with 415 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 1% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Naseem Eisa's median patient age at 59, with 76% women.

In 2024, Naseem Eisa wrote 2,280 Medicare Part D claims for 445 patients. 52% of them were for generic drugs. CMS names the drug for 1,969 of them, across 36 drugs with 11 or more claims each, at $857,745 in total drug cost. In 2023, CMS named 1,672 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Naseem Eisa for performance year 2024, reported as part of a group. Naseem Eisa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Naseem Eisa as offering telehealth.

Dmand AI links 21 papers to Naseem Eisa, published from 2013 to 2018. 2013 was the busiest year, with 12. The most frequent topics are Tomography, X-Ray Computed, Adenocarcinoma and Diagnosis, Differential. Naseem Eisa has published most often in BMJ Case Rep. Naseem Eisa's most frequent co-authors are M. Chadi Alraies, MD, Fayez M. Kheir, MD and Amara Nidimusili.

CMS Open Payments shows 208 general payments to Naseem Eisa from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Medtronic MiniMed, Inc. paid the most, $696.

Naseem Eisa graduated from Damascus University Faculty of Medicine in 2008.

Naseem Eisa is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.